Navigation Links
Express Scripts Acquires SmartD Medicare Prescription Drug Plan; Adds to Industry-Leading Medicare Offering
Date:9/9/2013

ST. LOUIS, Sept. 9, 2013 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced the strategic acquisition of the SmartD Medicare Prescription Drug Plan (PDP) which will add 87,000 covered Medicare lives. Terms of the deal were not disclosed.

(Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO)

"Working together with independent and chain pharmacies, we look forward to serving SmartD members and we are pleased in the continued growth and enhancement of our Medicare PDP offering," said Brit Pim, vice president and general manager, government programs at Express Scripts. "We are proud of our track record of success in administering Medicare prescription drug plans and that's due to our expertise in and commitment to member service."

Express Scripts serves millions of Medicare beneficiaries on behalf of our health plans, our Employer Group Waiver Plan (EGWP) clients as well as through our own national Express Scripts Medicare PDP, which has consistently earned high Center for Medicare Services (CMS) Star Ratings. In 2013, the plan earned four out of five possible stars – the highest of any nationally offered PDP.**

"We have the right people and processes to ensure Express Scripts consistently delivers advanced health and safety solutions, driven by a compliance-first culture, to meet the needs of the Medicare marketplace," said Pim. "We're committed to continuing investing in this area, developing and expanding programs that help Medicare beneficiaries and plan sponsors make better decisions and realize healthier outcomes."

Express Scripts Medicare Advisors and pharmacists are available 24 hours a day/7 days a week to help lower costs, alert beneficiaries to the Coverage Gap and offer guidance on ways to delay reaching it.

**A 2013 4-star-rated plan in 49 states and 3.5 stars in NY. Plan performance summary star ratings are assessed each year and may change from one year to the next.

About Express Scripts

Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients — employers, health plans, unions and government health programs — we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities — behavioral sciences, clinical specialization and actionable data — to create Health Decision Science(SM), our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy-benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

MEDIA CONTACT:
David Whitrap
Director, Corporate Communications
314-684-6514
dwhitrap@express-scripts.com

INVESTOR CONTACT:
David Myers
Vice President, Investor Relations
314-810-3115
investor.relations@express-scripts.com


'/>"/>
SOURCE Express Scripts
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board
2. Express Scripts To Discuss Outlook for Future Growth
3. Suture Express Announces New Board Chairman
4. Patients and Physicians Express Desire to Switch to Transdermal Drug Delivery, Finds Frost & Sullivan
5. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
6. Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
7. Express Scripts Reports First Quarter 2013 Results
8. Bipartisan Group of 124 Lawmakers Express Concern That Medicare Cuts to Life-Sustaining Cancer Drugs Threatening Patient Care
9. Express Scripts Holding Company Announces First Quarter 2013 Earnings Conference Call
10. Express Scripts Research Shows Prescription Drug Utilization Declines for Payers of Workers Compensation
11. Express Scripts Recommends Rejection of TRC Capitals "Mini-Tender" Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):